Top Buys by Directors: Dorman's $1.5M Bet on CVS

Shutterstock photo

The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money - maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So in this series we look at the largest insider buys by company directors over the trailing six month period, one of which was a total of $1.5M by David W. Dorman, Director at CVS Health Corporation (Symbol: CVS).

Purchased Insider Title Shares Price/Share Value
05/04/2018 David W. Dorman Director 24,300 $62.22 $1,511,868.24

Dorman's average cost works out to $62.22/share. In trading on Monday, bargain hunters could buy shares of CVS Health Corporation (Symbol: CVS) and achieve a cost basis lower than Dorman, with shares changing hands as low as $62.00 per share. Shares of CVS Health Corporation were changing hands at $62.08 at last check, trading off about 1.5% on Monday. The chart below shows the one year performance of CVS shares, versus its 200 day moving average:

CVS Health Corporation Chart

Looking at the chart above, CVS's low point in its 52 week range is $60.14 per share, with $84 as the 52 week high point - that compares with a last trade of $62.08.

The current annualized dividend paid by CVS Health Corporation is $2/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 04/20/2018. Below is a long-term dividend history chart for CVS, which can be of good help in judging whether the most recent dividend with approx. 3.2% annualized yield is likely to continue.


According to the ETF Finder at ETF Channel, CVS makes up 5.38% of the First Trust Consumer Staples AlphaDEX Fund ETF (Symbol: FXG) which is trading higher by about 0.3% on the day Monday.

Click here to find out which other top insider buys by company directors you need to know about »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Options
Referenced Symbols: CVS , FXG

More from BNK Invest


BNK Invest

BNK Invest

Market News, Investing

Research Brokers before you trade

Want to trade FX?